ArticleThe oncologist2023

Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer.

Allison L Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.